TrialEuropean journal of heart failure2021

A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.

Roberto Bolli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.